The analysts with a positive outlook observe that PKI has been actively honing its business model in favor of high-growth product lines through acquisitions and divestitures.  PKI continues to see improved performance across the majority of its business, as rebounding end markets and cost containment measures helped to drive a top and bottom line growth.  Moreover, the analyst note that PKI continued to invest in a number of growth initiatives especially in China, despite challenging economic conditions. This balanced approach has allowed PKI to exit FY09 stronger and better positioned strategically.  The analysts expect that PKI will continue to expand operating margins due to its active cost management and transfer of select manufacturing to Asia.  Overall, PKI is experiencing continued adoption of products in select areas such as diagnostics, food, and environment.  The estimated return over the current price is 21.4%.